| 摘要 |
<p>The present invention relates to a pharmaceutical preparation for treating an inflammatory condition, preferably a condition associated with ischemia comprising
a) a physiological solution comprising peripheral blood mononuclear cells (PBMCs) or a subset thereof, or
b) a supernatant of the solution a), wherein the solution a) is obtainable by cultivating PBMCs or a subset thereof in a physiological solution free of PBMC-proliferating and PBMC-activating substances for at least 1 h.</p> |
